Mitchell H. Gold
2021
In 2021, Mitchell H. Gold earned a total compensation of $3.1M as Executive Chairman and Chief Executive Officer at Nivalis Therapeutics, a 125% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,700 |
|---|---|
| Option Awards | $2,287,813 |
| Salary | $523,000 |
| Total | $3,111,513 |
Gold received $2.3M in option awards, accounting for 74% of the total pay in 2021.
Gold also received $300.7K in non-equity incentive plan and $523K in salary.
Rankings
In 2021, Mitchell H. Gold's compensation ranked 4,289th out of 12,415 executives tracked by ExecPay. In other words, Gold earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,289 out of 12,415 | 66th |
Division Manufacturing | 1,770 out of 5,505 | 68th |
Major group Chemicals And Allied Products | 741 out of 2,375 | 69th |
Industry group Drugs | 662 out of 2,096 | 68th |
Industry Pharmaceutical Preparations | 469 out of 1,546 | 70th |
Source: SEC filing on April 29, 2022.
Gold's colleagues
We found three more compensation records of executives who worked with Mitchell H. Gold at Nivalis Therapeutics in 2021.